Commit To Buy Acadia Pharmaceuticals At $18, Earn 11.4% Using Options
July 19, 2016 at 11:39 AM EDT
Investors eyeing a purchase of Acadia Pharmaceuticals Inc (ACAD) shares, but cautious about paying the going market price of $32.98/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $18 strike, which has a bid at the time of this writing of $2.05..